Atlas Technical Consultants, Inc.
(ATCX)
Monteverde & Associates Announces the Investigation of Atlas Technical Consultants, Inc.
Concert Pharmaceuticals, Inc.
(CNCE)
Monteverde & Associates Announces the Investigation of Concert Pharmaceuticals, Inc.
Leap Therapeutics, Inc.
(LPTX)
Monteverde & Associates Announces the Investigation of Leap Therapeutics, Inc.
Angion Biomedica Corp.
(ANGN)
Monteverde & Associates Announces the Investigation of Angion Biomedica Corp.
Golden Matrix Group, Inc.
(GMGI)
Monteverde & Associates Announces the Investigation of Golden Matrix Group, Inc.
Duck Creek Technologies, Inc.
(DCT)
Monteverde & Associates Announces the Investigation of Duck Creek Technologies, Inc.
Paya Holdings Inc.
(PAYA)
Monteverde & Associates Announces the Investigation of Paya Holdings Inc.
Albireo Pharma, Inc.
(ALBO)
Monteverde & Associates Announces the Investigation of Albireo Pharma, Inc.
CinCor Pharma, Inc
(CINC)
Monteverde & Associates Announces the Investigation of CinCor Pharma, Inc
Amryt Pharma Plc
(AMYT)
Monteverde & Associates Announces the Investigation of Amryt Pharma Plc
Catalyst Biosciences, Inc.
(CBIO)
Monteverde & Associates Announces the Investigation of Catalyst Biosciences, Inc.
Horizon Global Corp.
(HZN)
Monteverde & Associates Announces the Investigation of Horizon Global Corp.
Maxar Technologies, Inc.
(MAXR)
Monteverde & Associates Announces the Investigation of Maxar Technologies, Inc.
